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1. Data description {#sec1}
===================

The present data focuses on the average and individual plasma bioavailability of human adult males and females after the intake of a single dose of a multivitamin drink. Bioavailability of small and medium molecules can vary widely in humans \[[@bib1], [@bib2], [@bib3]\], which in further consequence lead to heterogeneous biological biomarker outcome measures \[[@bib4]\].

A single dose of a multivitamin drink was consumed from healthy male and female adults and defined biomarker, which were part of the drink, measured in the blood of the participants at baseline and periodically up to 6h after intake.

Plasma response of folate, vitamin B12 the resveratrol metabolites resveratrol-3-*O*-glucuronide (R3G), resveratrol-4′-*O*-glucuronide (R4G), resveratrol-3-*O*-sulfate (R3S) and resveratrol-3-*O*-4′-*O*-disulfate (RD) as well as the biological outcome parameter MDA and FRAP were measured at every blood sampling time point ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Plasma concentrations of MDA, FRAP, vitamin B12, folic acid, resveratrol-3-*O*-glucuronide (R3G), resveratrol-4′-*O*-glucuronide (R4G), resveratrol-3-*O*-sulfate (R3S) and resveratrol-3-*O*-4′-*O*-disulfate (RD) at baseline and 60, 120, 240 and 360 min after intake of a multivitamin drink. Each point represents the single response of a participant. The full line represents the mean of the group.Fig. 1

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Design and blood sampling {#sec2.1}
------------------------------

Presented data are coming from a single administration dose response after the intake of 33 ml (equivalent to a recommended daily dose) of a multivitamin beverage (vabo-n essentials ©), which consisted of micronutrients and active plant compounds, among them folate, vitamin B12 and resveratrol. 10 healthy adult volunteers (5 males, 5 females, mean age 29.6 ± 7.5 (21--45) years, mean weight 77,1 ± 22,0 (55--121) kg, mean height 174 ± 12 (158--194) cm), were recruited according to defined inclusion and exclusion criteria. In the morning the drink was administered to the subjects (after a 12h overnight fast) and blood was taken at baseline and after 1, 2, 4 and 6 hours with repeated venepunctures. The baseline plasma levels were for MDA 0,60 ± 0,13 μg/l, for folic acid 3,12 ± 1,3 μg/l, for vitamin B12 303 ± 104 ng/l and for FRAP 500 ± 111 mM TEAC. Resveratrol metabolites were not detectable at baseline.

Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki. The protocol was approved by the ethics committee of the University of Vienna (No. 00204).

Plasma/Serum was separated after centrifugation (10 min, 3.000 rpm) immediately after every blood sampling and stored at −80 °C until analysis.

2.2. Inclusion and exclusion criteria {#sec2.2}
-------------------------------------

Inclusion: males & females aged: 20--70 years, healthy and without chronic diseases, capable of signing the informed consent, no intake of vitamin and nutritional supplements 4 weeks prior study entry and over the whole study period; constant nutritional and physical activity habits 4 weeks prior study entry and over the whole study period.

Exclusion: males & females younger than 20 years and older than 71 years of age, acute diseases, chronic diseases (cardiovascular, pulmonary and metabolic diseases), pregnant and lactating women, morbid obesity (BMI\>40), participation in an other study 30 days prior to study entry, people with organ transplants, subjects with gastrointestinal malabsorption, HIV positive, substance abuse (e.g. alcohol \>80 g/d) within the last 2 years, intake of vitamin and nutritional supplements 4 weeks prior study entry and over the whole study period.

2.3. Analysis of malondialdehyde (MDA) {#sec2.3}
--------------------------------------

MDA levels were determined in duplicates in plasma as described earlier \[[@bib5]\]. After heating (60min, 100 °C) plasma samples were neutralized with methanol/NaOH, centrifuged (3min, 3000 rpm) and MDA was measured with high-performance liquid chromatography (HPLC) (excitation: λ = 532nm, emission: λ = 563nm, mobile phase: phosphate buffer:methanol = 60:40, HPLC column 125 × 4 mm, 5 μm; Merck, Vienna, Austria).

2.4. Analysis of the ferric reducing ability potential (FRAP) {#sec2.4}
-------------------------------------------------------------

The antioxidant capacity of serum was measured by performing the ferric reducing ability potential (FRAP) assay as described by Benzie and Strain \[[@bib6]\] in triplicates using trolox as standard. Absorbance was measured with at 593 nm and data are expressed as trolox equivalents in mM TEAC.

2.5. Analysis of folic acid and vitamin B12 {#sec2.5}
-------------------------------------------

Plasma concentrations of vitamin B12 and folate in plasma were measured by using radioimmunoassay. Standard curves were drawn and sample values calculated according to the protocol published by the kit producer (MP Biomedicals, Germany).

2.6. Analysis of resveratrol metabolites {#sec2.6}
----------------------------------------

Resveratrol and its glucuronidated and sulfated biotransformation products were quantified by HPLC as described previously \[[@bib7]\] using a Dionex UltiMate 3000 HPLC system equipped with an L-7250 injector, an L-7100 pump, an L-7300 column oven (set at 15 °C), a D-7000 interface and an L-7400 UV detector (Thermo Fisher Scientific, Waltham, Massachusetts) set at a wavelength of 307 nm. Separation was done on a Hypersil BDS-C18 column (5 μm, 250 × 4.6 mm I.D., Thermo Fisher Scientific, Inc., Waltham, MA), preceded by a Hypersil BDS-C18 guard column (5 μm, 10 × 4.6 mm I.D.) at a column temperature of 15 °C using a mobile phase consisting of a continuous gradient mixed from 5 mM ammonium acetate/acetic acid buffer, pH 7.4, and methanol at a flow rate of 1 ml/min. Calibration of the chromatogram was accomplished using the external standard method. Linear calibration curves were performed by spiking drug-free cell culture medium with standard solutions of resveratrol, resveratrol-3-*O*-sulfate, resveratrol-3-*O*-4′-*O*-disulfate, resveratrol-3-*O*-glucuronide and resveratrol-4′-*O*-glucuronide to give a concentration range from 0.001 to 10 μg/ml (average correlation coefficients: \>0.999). For this method the lower limit of quantification for resveratrol and resveratrol conjugates was 5 ng and 7 ng, respectively. Coefficients of accuracy and precision for these compounds were \<11%.

The outcome of all parameters are shown in [Fig. 1](#fig1){ref-type="fig"}. Raw data are shared as [supplementary file](#appsec1){ref-type="sec"}.

2.7. Statistical analysis {#sec2.7}
-------------------------

Statistical analyses were performed using IBM SPSS Statistics 23. To assess the overall differences between the time points, the Friedman test was conducted and if significant, the Wilcoxon test was used to calculate the differences between each time point by considering Bonferroni correction. The data are expressed as mean ± SEM (MIN -- MAX). P \< 0.05 was considered as statistically significant.
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